Published in Medical Patent Business Week, September 30th, 2005
WellGen is the first biotechnology company using nutrigenomics to discover and develop proprietary products that treat and prevent disease. WellGen uses its patented screening technology to screen naturally occurring compounds that are generally regarded as safe, against a panel of genes associated with wellness and disease.
The additional investment will support WellGen's growth plans for its nutrigenomics product pipeline. WellGen's key research programs...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Patent Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.